Futura Medical (LON:FUM) Issues Quarterly Earnings Results

Futura Medical (LON:FUM) posted its earnings results on Tuesday. The company reported GBX 0.43 ($0.01) EPS for the quarter, Digital Look Earnings reports. Futura Medical had a negative net margin of 44.64% and a negative return on equity of 56.44%.

Futura Medical Price Performance

LON:FUM opened at GBX 9.55 ($0.13) on Tuesday. The firm’s 50 day simple moving average is GBX 11.81 and its 200 day simple moving average is GBX 25.35. The company has a market cap of £29.77 million, a PE ratio of -7.88 and a beta of 1.25. Futura Medical has a one year low of GBX 8.47 ($0.11) and a one year high of GBX 45.56 ($0.60).

Futura Medical Company Profile

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.